Shree Ganesh Biotech India Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Net Loss of Shree Ganesh Biotech India reported to Rs 0.15 crore in the quarter ended March 2026 as against net loss of Rs 0.95 crore during the previous quarter ended March 2025. Sales declined 29.57% to Rs 2.12 crore in the quarter ended March 2026 as against Rs 3.01 crore during the previous quarter ended March 2025.

For the full year,net profit rose 35.71% to Rs 0.38 crore in the year ended March 2026 as against Rs 0.28 crore during the previous year ended March 2025. Sales declined 78.35% to Rs 4.97 crore in the year ended March 2026 as against Rs 22.96 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on 14 May 2026.

Net profit of Shree Ganesh Biotech India declined 58.44% to Rs 0.32 crore in the quarter ended December 2025 as against Rs 0.77 crore during the previous quarter ended December 2024. Sales declined 95.14% to Rs 0.70 crore in the quarter ended December 2025 as against Rs 14.41 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on 29 January 2026.

Powered by Capital Market - Live News